Medicare beneficiaries will see discounts averaging 63 percent on 10 frequently prescribed medications starting this month due to the Medicare Drug Price Negotiation Program.
The program, authorized by the Affordable Care Act in 2022, made it possible for Medicare to negotiate with pharmaceutical companies for the first time.
The result of that initial negotiation took effect on Jan. 1, lowering the price on medications prescribed to nearly one in six Medicare beneficiaries in 2023.
Patient advocate Merith Basey of Patients For Affordable Drugs said the negotiation brought overdue accountability to pharmaceutical manufacturers who have long charged higher prices to U.S. customers than to those in other countries….
Lower Prices for 10 Medicare Drugs Now in Effect: What to Know
